Reviews |
From the Institute of Pharmacology, University of Heidelberg, Germany.
Correspondence to Stefan Offermanns, Institute of Pharmacology, University of Heidelberg, Im Neuenheimer Feld 366, 69120 Heidelberg, Germany. E-mail stefan.offermanns{at}pharma.uni-heidelberg.de
This Review is part of a thematic series on Mechanisms, Models, and In Vivo Imaging of Thrombus Formation, which includes the following articles:
Activation of Platelet Function Through G ProteinCoupled Receptors
Platelets As Immune Cells: Bridging Inflammation and Cardiovascular Disease
In Vivo Thrombus Formation
Platelet Adhesion
Platelet Inhibitors and Thrombus Formation
Bernhard Nieswandt and Ulrich Walter Guest Editors
Because of their ability to become rapidly activated at places of vascular injury, platelets are important players in primary hemostasis as well as in arterial thrombosis. In addition, they are also involved in chronic pathological processes including the atherosclerotic remodeling of the vascular system. Although primary adhesion of platelets to the vessel wall is largely independent of G proteinmediated signaling, the subsequent recruitment of additional platelets into a growing platelet thrombus requires mediators such as ADP, thromboxane A2, or thrombin, which act through G proteincoupled receptors. Platelet activation via G proteincoupled receptors involves 3 major G proteinmediated signaling pathways that are initiated by the activation of the G proteins Gq, G13, and Gi. This review summarizes recent progress in understanding the mechanisms underlying platelet activation and thrombus extension via G proteinmediated signaling pathways.
Key Words: platelet activation heterotrimeric G proteins GPCRs thrombosis
This article has been cited by other articles:
![]() |
F. May, I. Hagedorn, I. Pleines, M. Bender, T. Vogtle, J. Eble, M. Elvers, and B. Nieswandt CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis Blood, October 15, 2009; 114(16): 3464 - 3472. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Collet and G. Montalescot Review: Platelet Function Testing and Implications for Clinical Practice Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2009; 14(3): 157 - 169. [Abstract] [PDF] |
||||
![]() |
H. L. Dauerman Reply J. Am. Coll. Cardiol., May 19, 2009; 53(20): 1922 - 1923. [Full Text] [PDF] |
||||
![]() |
J. Rivera, M. L. Lozano, L. Navarro-Nunez, and V. Vicente Platelet receptors and signaling in the dynamics of thrombus formation Haematologica, May 1, 2009; 94(5): 700 - 711. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, L. F. Brass, and D. R. Manning The Gq and G12 Families of Heterotrimeric G Proteins Report Functional Selectivity Mol. Pharmacol., January 1, 2009; 75(1): 235 - 241. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Freson, B. Izzi, V. Labarque, M. Van Helvoirt, C. Thys, C. Wittevrongel, M. Bex, R. Bouillon, N. Godefroid, W. Proesmans, et al. GNAS Defects Identified by Stimulatory G Protein {alpha}-Subunit Signalling Studies in Platelets J. Clin. Endocrinol. Metab., December 1, 2008; 93(12): 4851 - 4859. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Minuz Nonsteroidal Anti-Inflammatory Drugs and Cardiovascular Risk: Is Prostacyclin Inhibition the Key Event? J. Am. Coll. Cardiol., November 11, 2008; 52(20): 1637 - 1639. [Full Text] [PDF] |
||||
![]() |
D. Varga-Szabo, A. Braun, C. Kleinschnitz, M. Bender, I. Pleines, M. Pham, T. Renne, G. Stoll, and B. Nieswandt The calcium sensor STIM1 is an essential mediator of arterial thrombosis and ischemic brain infarction J. Exp. Med., July 7, 2008; 205(7): 1583 - 1591. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Varga-Szabo, I. Pleines, and B. Nieswandt Cell Adhesion Mechanisms in Platelets Arterioscler Thromb Vasc Biol, March 1, 2008; 28(3): 403 - 412. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kawato, R. Shirakawa, H. Kondo, T. Higashi, T. Ikeda, K. Okawa, S. Fukai, O. Nureki, T. Kita, and H. Horiuchi Regulation of Platelet Dense Granule Secretion by the Ral GTPase-Exocyst Pathway J. Biol. Chem., January 4, 2008; 283(1): 166 - 174. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Davi and C. Patrono Platelet Activation and Atherothrombosis N. Engl. J. Med., December 13, 2007; 357(24): 2482 - 2494. [Full Text] [PDF] |
||||
![]() |
T. Ohmori, Y. Kashiwakura, A. Ishiwata, S. Madoiwa, J. Mimuro, and Y. Sakata Silencing of a Targeted Protein in In Vivo Platelets Using a Lentiviral Vector Delivering Short Hairpin RNA Sequence Arterioscler Thromb Vasc Biol, October 1, 2007; 27(10): 2266 - 2272. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Meadows and D. L. Bhatt Clinical Aspects of Platelet Inhibitors and Thrombus Formation Circ. Res., May 11, 2007; 100(9): 1261 - 1275. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. J.H. Sachs and B. Nieswandt In Vivo Thrombus Formation in Murine Models Circ. Res., April 13, 2007; 100(7): 979 - 991. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |